drugset / Press release
Ultragenyx Investigational New Drug Application for Triheptanoin for the Treatment of Glucose Transporter Type-1 Deficiency Syndrome is in Effect
2013-12-17 · Ultragenyx Pharmaceutical Inc · original ultragenyx.com ↗
Ultragenyx Investigational New Drug Application for Triheptanoin for the Treatment of Glucose Transporter Type-1 Deficiency Syndrome is in Effect
The release as fetched from its publisher. ultragenyx.com ↗